Live News
Home » News » The ‘India Pharma Week’ returns with a week full of avant-garde events alongside CPhI and P-MEC India

The ‘India Pharma Week’ returns with a week full of avant-garde events alongside CPhI and P-MEC India

A distinguished assemblage of Leadership, Business, Knowledge, Networking, Recognition and Innovation in the Pharma domain by UBM India

  • South Asia’s largest Pharma event
  • CPhI and P-MEC India to be held at two different venues i.e., MMRDA Grounds (BKC), Mumbai – 27th to 29th Nov ;  the Bombay Exhibition Centre (Goregaon) – 28th to 30th Nov
  • 1500+ exhibitors ; 40+ countries
  • More than 10 eclectic events across Mumbai throughout the India Pharma Week

Mumbai, November 22nd, 2017: UBM India, India’s leading B2B exhibition organizer, is all set to bring in the second edition of the widely appreciated India Pharma Week, a week-long celebration packed with avant-garde events from 25th to 30th November alongside its flagship expo CPhI and P-MEC India. In its 11th edition, the marquee expo will be held at two venues in Mumbai – MMRDA Grounds, Bandra Kurla Complex (27th to 29th November) and Bombay Exhibition Centre (28th to 30th November).

Celebrating 11 years of CPhI and P-MEC India, the India Pharma Week will organise more than 10 events and activities taking place across the city of Mumbai pertaining to the streams of business, knowledge, leadership, innovation, recognition and networking in the field of Pharma. The week will commence with a Plant visit followed by a series of engagements such as Pharma Leaders Golf, Pre-Connect Congress, Women in Pharma – Power Breakfast, India Pharma Awards, Networking Evening, the CPhI & P-MEC India Exhibition, a closed-door CEO Roundtable and many more activities.

Incepted in 2006, the CPhI & P-MEC India exhibition has grown remarkably larger over the years with exhibitors and visitors engaging over significant levels of business. It has been approved and comprehensively assisted in its endeavours by governing bodies such as Pharmaceuticals Export Promotion Council (Pharmexcil).  Spread across two locations, this year’s edition will see more than 1500 exhibitors and participation from over 40 countries.

_____

Speaking on the announcement of the IPW, Mr. Yogesh Mudras, Managing Director, UBM India said, “I am delighted to announce the second edition of the weeklong India Pharma Week, an unrivalled offering to the world of exhibitions along with the CPhI & P-MEC India, UBM’s flagship engagement platform, and the world’s leading Pharmaceutical networking event. An epitome of India’s strength in the Pharma industry, the expo has consistently grown to serve as an exclusive congregation of key global players across the pharmaceutical sector. Over the past few years, India is seen as a potential market for global pharmaceutical manufacturers and is now ready to transform into a global pharmacy hub. The various economic drivers and government policies like pharma parks, boosting the Biosimilars and biologics sector along with ancillary sectors, and reducing manufacturing costs are the key driving factors for the growth of the sector in the country. The ‘Pharma Vision 2020′ which was introduced to make India a global leader in end-to-end drug manufacturing has also boosted investments.”

“The India Pharma Week stems from the proactive role it plays in driving key Governmental initiatives such as ‘Make in India’, ‘Start-Up India, Stand Up India’, and ‘Skill India’ connecting the global community to eke out solutions to challenges, and establishing superior standards within it. With the recent proposal by the Drug Controller General of India (DCGI) to make it mandatory for all employees in pharmaceutical manufacturing facilities to get skill certification, a notable congregation of industry experts and knowledge sharing, such as IPW provides becomes even more significant,” he further added.

About the Cphi-PMEC expo:

Originating from CPhI Worldwide – CPhI India has become South Asia’s leading Pharma meeting place covering every step of the supply chain from drug discovery to finished dosage, encompassing CROs, CMOs and manufacturers of API, Generics, Excipients and Drug formulation, Fine chemicals, Biosimilars, Finished Formulations, Lab chemicals and Biotechnology.

P-MEC, on the other hand, includes manufacturers of Pharma Machinery and Equipment, Analytical Equipment, Automation & Robotics, Packaging Equipment & Supplies, Plant / Facility Equipment, Automation & Controls, Processing Equipment, RFID, Tableting / Capsule fillers, Clean room equipment, Filling equipment and Laboratory products.

The pharma scenario in India

Renowned as the pharmacy of the world, the Indian pharma economy has been lauded for its rapid growth in recent decades. This has cooled down in recent years, but the industry is again growing strongly. Compounded annual growth is 17.6%; Indian pharma is expected to be worth 55 billion USD by 2020. In line with this, the life science sector in India is also expected to employ close to 3.5 million people by 2022, a 100% increase in under a decade. The Indian pharma industry owes its success to its bold, ambitious approach, history of innovative and an ability to constantly adapt to the dynamic global market.

Over the past five years, India has become the leading API and finished dose drug exporter to the Western markets and has rapidly moved up the pharmaceutical value chain. Drug approvals given by the US Food and Drug Administration (USFDA) to Indian companies have nearly doubled from 109 (2014-2015) to 201 (2015-2016), stimulating further growth in exports to the United States and Western economies. Additionally, the Indian government is now providing more support working hand-in-hand with its businesses to develop incentives to further boost growth.

More generally, the country is now rapidly emerging as a major contributor across the pharma supply chain from R&D through to generics.

About UBM India:

UBM India is India’s leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in.

About UBM plc:

UBM plc is the largest pure-play B2B Events organiser in the world.  In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important.  At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses.  Our 3,750+ people, based in more than 20 countries, serve more than 50 different sectors – from fashion to pharmaceutical ingredients.  These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions.

For more information, go to www.ubm.com; for UBM corporate news, follow us on Twitter at @UBM ,UBM Plc LinkedIn

For any media queries please contact:

UBM India

Roshni Mitra / roshni.mitra@ubm.com

Mili Lalwani/ mili.lalwani@ubm.com

+91-22-61727000